. Author manuscript; available in PMC: 2020 Oct 13.

Published in final edited form as: Leukemia. 2018 Jan 30;32(10):2203–2210. doi: 10.1038/s41375-018-0027-y

Table 1.

Distribution of patients with myeloproliferative neoplasms and their matched population controls. PV=polycythemia vera, ET=essential thrombocythemia, PMF=primary myelofibrosis, MPN-U=myeloproliferative neoplasm, unclassifiable, n=number

	Patients (n)	Controls (n)
Men	4 502 (48%)	16 992 (48%)
Women	4 877 (52%)	18 690 (52%)
Age 18-49	1 004	4 016
Age 50-59	1 341	5 363
Age 60-69	2 235	8 938
Age 70-79	3 087	12 032
Age 80+	1 712	5 333
Median age	67.5 years	66.6 years
Period 1973-1982	1 545	5 995
Period 1983-1992	2 213	8 468
Period 1993-2001	2 692	10 160
Period 2002-2009	2 929	11 059
PV	4 214 (45%)	-
ET	2 660 (28%)	-
PMF	1 392 (15%)	-
MPN-U	1 113 (12%)	-
Total	9 379	35 682